Richard A. Zordani Jr., Director at GALECTIN THERAPEUTICS INC (GALT), bought 3,500 shares at $2.30 ($8K) on 2024-08-23, disclosed to the SEC on 2024-08-26.
Open-market purchase of $8k GALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.30 | 741 | $2K | 21.2% |
| 2 | $2.30 | 1,000 | $2K | 28.6% |
| 3 | $2.30 | 1,759 | $4K | 50.3% |
| Total | $2.30 avg | 3,500 | $8K | 100% |
| Filing → |
| GALT | BUY | 2022-07-29 | $13K | — | Filing → |
| GALT | BUY | 2022-04-04 | $8K | — | Filing → |
| GALT | BUY | 2022-01-18 | $10K | — | Filing → |